Richard Pelzl^1*, Sabrina Kübel^2*, Paulina Klein^2*, Franziska Gsottberger, MSc^3*, Kerstin Wendland^4*, Srdjan Petkovic^4*, Valeska Brueckl, MD^3*, Rebecca Baur, MD^3*, Simon Voelkl, PhD^3*, Andreas Mackensen, MD^3*, Krystelle Nganou-Makamdop, PhD^2* and Fabian Müller, MD^3*

¹Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-University Erlangen-Nürnberg, Nürnberg, Germany
²Department of Virology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
³Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
⁴Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany

Suvi-Katri Leivonen, PhD¹, Terhi Friman, MD^2*, Samuli Vaittinen, MD, PhD^3*, Andreas Wind Jensen, MD^4*, Francesco Annibale d'Amore, MD, DMSc⁴, Stephen Jacques Hamilton-Dutoit, MD, PhD^5*, Harald Holte, MD, PhD⁶, Klaus Beiske, MD, PhD^7*, Panu Kovanen, MD, PhD^8*, Riikka Räty, MD, PhD^2* and Sirpa Leppa, MD, PhD⁹

¹Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland
²Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
³Department of Pathology, Turku University Hospital, Turku, Finland
⁴Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
⁵Department of Pathology, Aarhus University Hospital, Aarhus, Denmark
⁶Department of Oncology, Oslo University Hospital, Oslo, Norway
⁷Oslo University Hospital, Oslo, Norway
⁸Helsinki University Hospital, Helsinki, Finland
⁹Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland

Genevive H. Hernandez, PhD^1*, John So, BS^2*, Kathryn A. Logronio, BS^2*, Maya F. Kotturi, PhD^2*, Won Seog Kim, MD PhD^3*, Philippe Armand, MD PhD⁴, Chan Yoon Y. Cheah, MD⁵, Ajay K. Gopal, MD⁶, Ian W. Flinn, MD PhD⁷, Gareth P. Gregory, MBBS, PhD, FRACP, FRCPA⁸, Matthew J. Matasar, MD, MS⁹, Loretta J. Nastoupil, MD¹⁰, Catherine S. Diefenbach, MD¹¹, Sung-Soo Yoon, MD, PhD¹², Matthew Ku, MBBS PhD¹³, Ibrahim Qazi, PharmD^2*, Maya K. Leabman, PhD^2*, Iris Sison, BS^2*, Bruce A. Keyt, PhD², Chris H. Takimoto, MD PhD², Thomas J. Manley, MD² and Elizabeth L. Budde, MD, PhD¹⁴

¹IGM Bio Sciences, Mountain View, CA
²IGM Biosciences, Inc., Mountain View, CA
³Division of Hematology-Oncology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
⁴Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁵Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, WEA, Australia
⁶University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA
⁷Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN
⁸School of Clinical Sciences at Monash Health, Monash University, Caulfield South, Australia
⁹215 West 90th St, 14E, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁰Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
¹¹Perlmutter Cancer Center at NYU Langone Health, New York, NY
¹²Division of Hematology/Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
¹³St Vincent's Hospital, University of Melbourne, Melbourne, Australia
¹⁴Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA

Sara ovejero-Merino, PhD^1,2*, Laura Alibert^3*, Julie Devin, PharmD^4,5*, Tatiana Cañeque^6*, Ouissem Karmous Gadacha^1,2*, Matthieu Abouladze^1,2*, Guilhem Requirand^2*, Nicolas Robert^2*, Hugues De Boussac, PhD^7*, Guillaume Cartron, MD, PhD^8,9*, Charles Herbaux^10,11,12, Raphael Rodriguez^6*, Jerome Moreaux, PhD^2,5,13,14 and Caroline Bret, PhD, PharmD^5,15,16*

¹Institute of Human Genetics, Montpellier, FRA
²Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, CHU Montpellier, Montpellier, France
³Institute of human genetics, Montpellier, France
⁴CHU Montpellier, Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, Montpellier, France
⁵Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France
⁶Institut Curie, Paris, France
⁷Diag2Tec, Prades Le Lez, France
⁸Département d'Hématologie clinique, CHU de Montpellier, Montpellier, France
⁹Department of Clinical Hematology, University Hospital of Montpellier, Montpellier, France
¹⁰Hematology Department, Montpellier University Hospital, Montpellier, France, Montpellier, France
¹¹University of Montpellier, Paris, France
¹²University of Montpellier, Montpellier, France
¹³UFR Médecine, Université Montpellier, Montpellier, France
¹⁴Institut Universitaire de France, Paris, France
¹⁵Department of Biological Hematology, CHU Montpellier, Montpellier, France
¹⁶University of Montpellier, UFR Medecine, Montpellier, France

Maciej Szydlowski, PhD^1*, Filip Garbicz^2*, Ewa Kurtz^3*, Justyna Żurańska, PhD^4*, Michał Seweryn, PhD^4*, Michał Pawlak, PhD^1*, Patryk Górniak, PhD^1*, Kamil Sokół^5*, Anna Szumera-Ciećkiewicz, MD, PhD^5*, Monika Kawecka^6*, Daria Owczarek^5*, Beata Puton^7*, Monika Prochorec-Sobieszek, MD, PhD^5*, Daniela Bellarosa, PhD^8*, Michał Kurlapski^9*, Jan Zaucha^10*, Paweł Wołkow, PhD^4* and Przemyslaw Juszczynski, MD, PhD^1*

¹Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
²Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Warszawa, Mazowieckie, Poland
³Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Warsaw, Poland
⁴Center for Medical Genomics OMICRON, Jagiellonian University Medical College, Cracow, Poland
⁵Department of Diagnostic Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
⁶Department of Diagnostic Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Warsaw, Poland
⁷Department of Diagnostic Hematology, Institute of Hematology, Warsaw/Poland, Poland
⁸Experimental and Translational Oncology Department, Menarini Ricerche S.p.A., Pomezia (rome), AL, Italy
⁹Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland
¹⁰Medical University of Gdańsk, Gdańsk, Poland

Lixin Rui, PhD

Department of Medicine and Carbone Cancer Center, University of Wisconsin School of Medicine, Madison, WI

Janneke A. Eken, MSc^1*, Marvyn T. Koning, MD^1*, Julieta H. Sepulveda Yanez, MSc^1*, Cornelis A.M. van Bergen, PhD^1*, Edwin Quinten, BSc^1*, Kristyna Kupcova, PhD^2*, Ondrej Havranek, MD, PhD², Ruben A.L. De Groen, MSc^1*, Joost S.P. Vermaat, MD, PhD¹, Daphne de Jong, MD, PhD^3*, Philip Kluin, MD, PhD^4*, Arjen Cleven, PhD^5*, Hassan Jumaa, PhD^6* and Hendrik Veelken, MD, PhD¹

¹Department of Hematology, Leiden University Medical Center, Leiden, Netherlands
²BIOCEV, First Faculty of Medicine, Charles University, Prague, Czech Republic
³Department of Pathology, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, Netherlands
⁴University Medical Center Groningen, Groningen, Netherlands
⁵Department of Pathology, Leiden University Medical Center, Leiden, Netherlands
⁶Institut für Immunologie Universitätsklinikum Ulm, Ulm, Germany

Yixin Yao, PhD¹, Yang Liu, PhD^1*, Yuxuan Che^1*, Yijing Li, MS^1*, Heng-Huan Lee, PhD^1*, Michael L. Wang, MD^1,2 and Joseph McIntosh, BS^1*

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Ling-Yuh Huw^1*, Feifei Li^1*, Anton Belousov^2*, Hemanth Ramesha^1*, Christopher R. Bolen^1*, Michael C. Wei¹, Shen Yin¹, David C. Turner^1* and Elicia Penuel^1*

¹Genentech, Inc., South San Francisco, CA
²F. Hoffmann-La Roche, Ltd., Basel, Switzerland

Tanaya Shree, MD, PhD¹, Sarah Haebe, MD^1*, Debra K. Czerwinski², Erik Eckhert, MD, MS³, Grady Day^1*, Anuja Sathe, MD, PhD^1*, Susan M. Grimes, BSc^4*, Matthew J Frank, MD, PhD⁵, Lauren S. Maeda, MD^6*, Ash A. Alizadeh, MD, PhD⁷, Ranjana H. Advani, MD⁸, Richard Hoppe, MD⁹, Steven R. Long, MD^10*, Brock Martin, MD^11*, Michael G. Ozawa, MD, PhD^11*, Michael S. Khodadoust, MD PhD¹², Hanlee P. Ji, MD^1* and Ronald Levy, MD¹

¹Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA
²Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, CA
³Stanford University, Stanford, CA
⁴Stanford Genome Technology Center, Stanford University, Stanford, CA
⁵Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA
⁶Department of Medicine, Divisions of Hematology & Oncology, Stanford University Medical Center, Stanford, CA
⁷Divisions of Oncology and Hematology, Department of Medicine, Stanford University School of Medicine, San Mateo, CA
⁸Department of Medicine, Division of Oncology, Stanford University, Stanford, CA
⁹Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
¹⁰Department of Pathology, University of California San Francisco, San Francisco, CA
¹¹Department of Pathology, Stanford University School of Medicine, Stanford, CA
¹²Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA

Chuquan Shang^1*, Will Chen, MD^1*, Justine Lai^2*, Moinul Haque^1*, Peng Wang, MD, PhD² and Raymond Lai, MD, PhD^1*

¹Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada
²Department of Medicine, University of Alberta, Edmonton, AB, Canada

Jordan Blum, PhD^1*, Gregg Masters, MS^1*, Christopher Chiu, PhD¹, Han Si, PhD^2*, Jeremy Gale, MS^1*, Lisa Grimm, BS^1*, Manling Ma-Edmonds, MS^1*, Matthew Loya, BS^1*, Mahesh Bachu, PhD^1*, Omar Jabado, PhD^1*, David Soong, PhD², Jimin Zhang, PhD^1*, Monica Wielgos-Bonvallet, PhD^1*, Nicole Bottrel, MS^1*, Erin Henitz, MSc^1*, Brandon Higgs, PhD^2*, Kate Sasser, PhD^1*, Maria Jure-Kunkel, PhD, DVM^1* and Mark Fereshteh, PhD^1*

¹Translational Research and Precision Medicine Operations, Genmab, Princeton, NJ
²Translational Data Science, Genmab, Princeton, NJ

Soraya Carrancio^1*, Wen-Chi Chou^2*, Alberto Risueño, PhD^3*, Carla Guarinos^4*, Gonzalo Lopez^5*, Jean-Marie Michot, MD^6*, Loretta J. Nastoupil, MD⁷, Julio Chavez⁸, Cecilia Carpio^9*, Silvia Ferrari, MD^10*, Tatyana A. Feldman, MD¹¹, Daniel Morillo Giles^12*, Antonio Pinto, MD^13*, Danielle Greenawalt^14*, Daniel W. Pierce^15* and Michael Pourdehnad^16*

¹Oncogenesis (ONC) Thematic Research Center (TRC), Bristol Myers Squibb, San Diego, CA
²Early Development Predictive Sciences, Bristol Myers Squibb, Cambridge, MA
³Early Development Predictive Sciences, Center for Innovation and Translational Research Europe (CITRE), Bristol Myers Squibb, Seville, Spain
⁴ONC TRC, Center for Innovation and Translational Research Europe (CITRE), Bristol Myers Squibb, Seville, Spain
⁵Translational Bioinformatics, Bristol Myers Squibb, Summit, NJ
⁶Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy Institute of Cancer, Villejuif, France
⁷Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
⁸Department of Malignant Hematology, Moffitt Cancer Center, University of South Florida, Tampa, FL
⁹Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Autonomous University of Barcelona (UAB), Barcelona, Spain
¹⁰Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
¹¹Lymphoma Division, John Theurer Cancer Center at Hackensack Meridian Health, Hackensack, NJ
¹²Department of Hematology, University Hospital Fundación Jiménez Díaz, Madrid, Spain
¹³Hematology-Oncology & Stem Cell Transplantation Unit, National Cancer Institute, Fondazione G. Pascale, IRCCS, Naples, Italy
¹⁴Early Development Predictive Sciences, Bristol Myers Squibb, Princeton, NJ
¹⁵Oncogenesis Translational Research, Bristol Myers Squibb, San Francisco, CA
¹⁶Early Clinical Development, Hematology/Oncology and Cell Therapy, Bristol Myers Squibb, San Francisco, CA

Xianhuo Wang, MD^1*, Tingting Zhang^1*, Hengqi Liu^1*, Sicong Zhang^1*, Lanfang Li^1*, Lihua Qiu^1*, Zhengzi Qian^1*, Shiyong Zhou^1*, Kai Fu^2,3 and Huilai Zhang, M.D.^1*

¹Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
²Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, Tianjin, China
³Pathology, Univ. of Nebraska Medical Ctr., Omaha, NE

Giorgia Chiodin, PhD^1*, Dylan Tatterton^1*, Patrick J Duriez, PhD^1*, Ayse Ertay, PhD^1*, Philip J Rock^2*, Benjamin Sale^1*, Stuart Lanham, PhD^1*, Luis Del Rio^1*, Carl Figdor, PhD^3*, Richard Burack, MD, PhD², Freda K Stevenson, PhD¹ and Francesco Forconi, MD, PhD^1,4*

¹School of Cancer Sciences, University of Southampton, Southampton, United Kingdom
²Department of Pathology and Laboratory Medicine/Hematopathology, University of Rochester Medical Center, Rochester, NY
³Department of Tumor Immunology, Radboud Insititute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands
⁴University of Southampton, University Hospital Southampton NHS Trust, Southampton, United Kingdom

Mikael Roussel^1*, Cedric Menard^2*, Delphine Rossille, PhD^3*, Julien Saint-Vanne, BS, MS^4*, Joelle Dulong^2*, Emmanuel Bachy, MD, PhD^5,6*, Herve Tilly, MD, PhD⁷, Delphine Pranger^8*, Franck Morschhauser, MD, PhD^9*, Luc Xerri, MD, PhD^10,11*, Guillaume Cartron, MD, PhD^12* and Karin Tarte, PhD¹³

¹INSERM U1236 /hematology laboratory/university hospital of Rennes, Rennes, France
²SITI laboratory, University Hospital Pontchaillou, Rennes, France
³INSERM U1236 /hematology laboratory/university hospital of Rennes, rennes, France
⁴INSERM U1236, Rennes, FRA
⁵Hospices Civils de Lyon and Université Claude Bernard Lyon 1, Lyon, France
⁶Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre Benite, France
⁷Hematology Department, Centre Henri Becquerel, Rouen, France
⁸Grand Hopital de Charleroi, Buvrinne, BEL
⁹Service des Maladies du Sang, CHU Lille, Lille, France
¹⁰Institut Paoli-Calmettes, Marseille, France
¹¹Bio-Pathology Department, Institute Paoli-Calmettes, Marseille, France
¹²Montpellier University, UMR CNRS 5235, Montpellier, France
¹³INSERM U1236 & CHU Rennes, Rennes, France

Zhuoya Yu^1*, Mengfei Ding^1*, Yiqing Cai^1*, Tiange Lu^1*, Xiaomin Chen^1*, Xiangxiang Zhou, PhD^1,2* and Xin Wang^1,2

¹Department of Hematology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China
²Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China

Linda Gräßel, MD^1*, Teresa Poggio, PhD^1,2*, Geoffroy Andrieux, PhD^2,3*, Irene Gonzalez-Menendez, PhD^4*, Stefanie Kreutmair^1,2,5*, Cornelius Miething, MD^1,2*, Federico Bonofiglio, PhD^6*, Ivonne Aidee Montes Mojarro, PhD^4*, Marie Follo, PhD^1*, Dietmar Pfeifer, PhD^1*, Falko Fend, MD^4*, Leticia Quintanilla-Martinez, MD⁴, Robert Zeiser, MD^1,2, Suzanne Turner, PhD^7,8*, Melanie Börries, PhD^2,3*, Justus Duyster^1,2* and Anna Lena Illert, MD^1,2*

¹Department of Hematology, Oncology, and Stem Cell Transplantation, University Medical Center Freiburg, Freiburg, Germany
²German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
³Institute of Medical Bioinformatics and Systems Medicine, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
⁴Department of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany
⁵Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland
⁶Veramed GmbH, Frankfurt am Main, Germany
⁷CEITEC, Masaryk University, Brno, Czech Republic
⁸Department of Pathology, University of Cambridge, Cambridge, United Kingdom

Shipra Goel, MD, MBBS¹, Brahm Segal, MD^2*, Elizabeth A. Griffiths, MD³, Francisco Hernandez-Ilizaliturri, MD², Pallawi Torka, MD³, Matthew J Cortese, MD, MPH³, Paola Ghione, MD⁴, Michael J. Nemeth, PhD⁵ and Jason Muhitch, PhD^6*

¹Infectious diseases, Roswell Park Comprehensive Care Center, Buffalo, NY
²Roswell Park Cancer Institute, Buffalo, NY
³Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁴Roswell Park Comprehensive Cancer Center, New York, NY
⁵Departments of Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, NY
⁶Roswell park Comprehensive cancer care center, Buffalo, NY